New Study Reveals the Key Factors That May Shape Dementia Risk in Women

Nearly two-thirds of all Alzheimer's disease cases in the United States occur in women. That number gets cited often enough that it risks becoming background noise - a statistic absorbed and then set aside, unexamined. But a landmark study published in May 2026 has asked a harder question than who gets diagnosed: why does it happen more in women, and which specific risk factors are driving the gap?

The answer, now backed by data from more than 17,000 adults, is both clarifying and urgent. Women do not simply face more dementia risk factors than men - they also appear more cognitively vulnerable to many of the same ones. The study, published in Biology of Sex Differences by researchers at the University of California San Diego School of Medicine, found that the disparity in Alzheimer's rates between women and men cannot be explained by longevity alone. Something more specific and more modifiable is happening - and it starts long before memory problems appear.

This article unpacks the study's key findings, explains the biological mechanisms behind women's heightened vulnerability, contextualizes the evidence within the broader science of sex differences in brain aging, and outlines the most evidence-backed strategies for cognitive protection.

The Study: What Researchers Did and Why It Matters

A Nationally Representative Dataset, 13 Risk Factors, 17,182 Adults

Researchers Megan Fitzhugh, PhD, and Judy Pa, PhD - both neuroscientists at UC San Diego School of Medicine - analyzed health and cognitive data from 17,182 individuals aged 40 and older, drawn from the Health and Retirement Study, a nationally representative cohort of U.S. adults in mid- to late-life. They examined 13 established, modifiable dementia risk factors: depression, obesity, physical inactivity, smoking, hearing loss, diabetes, hypertension, sleep problems, alcohol use, cholesterol levels, poor vision, social isolation, and education level. The average participant age was 69.

The study asked two distinct questions. First: which risk factors are more prevalent in women versus men? Second - and more critically: which risk factors have a stronger negative association with cognitive performance in women, regardless of how common they are?

The second question is what makes this study genuinely novel. Previous research has largely documented that women carry a higher burden of certain risk factors. This study demonstrated that the same risk factor can extract a measurably larger cognitive cost in a woman's brain than in a man's. The direction of effect was often similar across sexes. The magnitude was not.

The Core Finding: A Double Burden

The study revealed a double burden that may explain much of the sex disparity in Alzheimer's rates. Women were more likely than men to report depression (17% vs. 9%), physical inactivity (48% vs. 42%), sleep problems (45% vs. 40%), elevated cholesterol, poor vision, and lower educational attainment. Men were more likely to have hearing loss (64% vs. 50%), diabetes (24% vs. 21%), and heavy alcohol use (22% vs. 12%).

But beyond the prevalence data, the most significant finding was that several risk factors were more strongly linked to poorer cognitive performance in women. Hypertension and elevated BMI showed steeper negative associations with cognition in women than in men. Hearing loss and diabetes - both more common in men - were nonetheless associated with worse cognitive outcomes when they appeared in women. The cognitive cost of the same condition was larger in the female brain.

"Our study suggests that women may be at greater risk of dementia because they experience a greater number of risk factors, and because these risk factors reduce cognition to a greater degree than in men," the researchers concluded.

The Risk Factors That Hit Women Hardest

Hypertension and Metabolic Health: The Cardiovascular-Cognitive Link

Of all the findings in the study, the cardiovascular and metabolic results are among the most actionable. Hypertension was common in both groups - affecting approximately six in ten participants in both sexes. But hypertension showed steeper negative associations with cognition in women, particularly in women who developed it after age 65. Similarly, elevated BMI was more strongly linked to poorer cognitive scores in women in their 50s and 60s - a finding that intersects directly with the metabolic changes of the menopausal transition.

These findings are biologically consistent with what is known about the female brain's dependence on estrogen for vascular regulation. Estrogen is a well-known regulator of the brain's metabolic system - it governs glucose transport, aerobic glycolysis, and mitochondrial function in brain regions involved in cognition, including the medial temporal cortex and frontal lobes. As estrogen declines during perimenopause and menopause, the brain's metabolic efficiency drops, and its vulnerability to vascular insults - like those produced by untreated hypertension - increases.

For women, controlling blood pressure and maintaining healthy metabolic function is not just a cardiovascular priority. It may be one of the most direct levers available for reducing long-term dementia risk.

Depression: Twice as Common, Disproportionately Damaging

Depression was nearly twice as prevalent in women as in men in the study (17% vs. 9%) - and the association between depression and poorer cognitive performance was among the most consistent findings across the data. This is not a new observation; the relationship between depression and dementia has been documented for years. But the disproportionate prevalence of depression in women, combined with its cognitive consequences, makes it a particularly high-priority target for intervention.

Depression reduces hippocampal volume over time, impairs neural plasticity, elevates cortisol (which damages hippocampal neurons directly), and promotes neuroinflammation - all pathways that overlap with Alzheimer's disease pathology. Women's higher rates of depression are themselves partially driven by the hormonal transitions of perimenopause and postmenopause, creating a compounding cycle: falling estrogen increases depression risk, depression increases dementia risk, and estrogen decline independently increases Alzheimer's vulnerability.

Treating depression effectively - through psychotherapy, medication, lifestyle intervention, or some combination - is no longer merely a mental health priority in midlife women. It is an active dementia prevention strategy.

Physical Inactivity and Sleep Problems: The Two Most Prevalent and Most Addressable

Physical inactivity was reported by 48% of women in the study versus 42% of men, and sleep problems by 45% of women versus 40% of men. Both are modifiable. Both have well-established biological mechanisms linking them to cognitive decline.

Physical activity preserves hippocampal volume, promotes neurogenesis, reduces neuroinflammation, lowers blood pressure and insulin resistance - addressing multiple pathways simultaneously. The fact that women in this nationally representative cohort were significantly more sedentary than men, at a life stage when cognitive reserve is being actively built or eroded, represents a substantial and underaddressed prevention gap.

Sleep problems, meanwhile, impair the glymphatic system - the brain's nocturnal waste-clearance mechanism that flushes amyloid-beta and tau proteins from the interstitial space during deep sleep. Women with poor sleep had worse cognitive scores in the study, and the overlap between sleep disruption and the menopausal transition (hot flashes, night sweats, mood disruption) creates a particularly concentrated vulnerability window in midlife.

Hearing Loss and Diabetes: Risk Factors More Common in Men, More Damaging in Women

One of the most counterintuitive and scientifically important findings in the study is that hearing loss and diabetes - both more prevalent in men - were nonetheless associated with worse cognitive outcomes in women who had them. This asymmetry suggests that the female brain may respond more severely to these conditions regardless of their prevalence - a finding that challenges the instinct to focus dementia prevention efforts exclusively on conditions that are most common in a given group.

Hearing loss reduces cognitive stimulation and social engagement, both of which are protective for brain health. The mechanisms by which the female brain responds more severely to this sensory deprivation are not yet fully understood, but the study findings are consistent with other recent longitudinal data showing steeper cognitive decline over time in women with hearing loss.

Diabetes, similarly, impairs cerebral glucose metabolism in ways that interact with the brain's already-compromised metabolic efficiency during and after menopause. Other recent longitudinal studies report steeper cognitive declines over time in women compared to men with diabetes - adding independent corroboration to this study's cross-sectional finding.

Educational Attainment: A Structural Inequality With Brain Consequences

Women in the study had slightly lower average educational attainment than men - a finding that reflects well-documented structural inequalities in access to education across the generations represented in a cohort with an average age of 69. Education is considered a primary driver of cognitive reserve - the brain's resilience against pathological change. Higher educational attainment builds more robust neural networks that can compensate for early Alzheimer's pathology before symptoms appear.

The study found that education and cholesterol had stronger positive associations with cognitive performance in women than in men - suggesting that gains in educational engagement and intellectual activity may offer particularly valuable cognitive protection for women, both retrospectively (through lifelong cognitive enrichment) and prospectively (through continued engagement in complex activities in midlife and beyond).

The Biological Layer: Why the Female Brain Is More Vulnerable

Estrogen as the Brain's Metabolic Regulator

To understand why the same risk factors hit women harder, it helps to understand what estrogen does inside the brain - a dimension of women's health that has been profoundly underexplored until recently.

Estrogen is a master regulator of the female brain's metabolic system. It governs glucose transport into neurons, supports aerobic glycolysis, maintains mitochondrial efficiency, and regulates cerebral blood flow. In the hippocampus - the brain region most critical for memory formation and most vulnerable to early Alzheimer's pathology - estrogen receptors are densely expressed, and their activation supports synapse formation, neuronal survival, and anti-inflammatory signaling.

When estrogen declines at menopause, this entire metabolic and neuroprotective scaffolding becomes less stable. The brain becomes more dependent on glucose metabolism pathways that are less efficient without estrogen, more vulnerable to inflammation, and less resilient to the kinds of vascular insults produced by hypertension, diabetes, and elevated BMI. This is why cardiovascular and metabolic risk factors show steeper cognitive effects in women: they are hitting a brain that has, since menopause, been operating with reduced biological protection.

The Menopausal Brain: MRI and PET Imaging Evidence

The brain changes associated with menopause are now visible on imaging. At the 2026 AAN annual meeting, Yale University neurologist Carolyn Fredericks, MD, reported that MRI and PET studies show women in their 40s and 50s experience changes in brain connectivity - especially in memory circuits - linked to declining estrogen during menopause. A brain circuit critically important for short-term memory shows particularly significant changes in women during these decades in ways not seen in age-matched men.

A Northwestern University study published in May 2026 found that estrogen loss, aging, and female sex are closely linked to disruption of the extracellular matrix (ECM) in the hippocampus - a structural component of brain tissue essential for synaptic stability and memory consolidation. Females, but not males, showed this estrogen-dependent vulnerability at old age, potentially explaining the higher Alzheimer's risk in postmenopausal women.

The APOE ε4 Genotype: A Female-Specific Amplifier

One additional genetic dimension interacts with everything above. The APOE ε4 allele - the most significant known genetic risk factor for late-onset Alzheimer's disease - shows sex-specific effects on glial activation, tau pathology, and cognitive decline. Women carrying APOE ε4 appear to be at greater risk of Alzheimer's than men with the same genotype, and the interaction between APOE ε4 status and menopausal hormone changes is an active area of research.

A UCSD blood biomarker study published in JAMA Network Open in March 2026 found that elevated p-tau217 levels - a protein linked to Alzheimer's brain changes - were strongly associated with future mild cognitive impairment and dementia in cognitively healthy older women up to 25 years before symptoms appeared. This biomarker-based early detection finding reinforces the urgency of identifying high-risk women early - precisely when modifiable risk factor intervention is most powerful.

Why Sex-Tailored Prevention Is the Critical Next Step

The Problem With Universal Prevention Guidelines

"Prevention efforts may be more effective if they are tailored not just to risk factor prevalence, but to how strongly each factor affects cognition in women versus men," said first author Megan Fitzhugh. This statement carries a specific scientific weight. Standard dementia prevention guidelines treat the 13 modifiable risk factors identified by the Lancet Commission as broadly applicable to all adults. They are. But this study demonstrates that a woman managing hypertension, depression, physical inactivity, and poor sleep simultaneously may be carrying a cognitive risk burden that is substantially greater than what those same four factors would mean for a man of the same age.

The practical implication is not that different risk factors need to be identified for women, but that the prioritization and intensity of intervention should be calibrated by sex. A modest blood pressure reduction may yield greater cognitive benefit in a postmenopausal woman than in her male counterpart. Treating depression aggressively in a woman in her 50s may provide more dementia protection than the same treatment would in a man of the same age. Physical activity programs designed for middle-aged women - accounting for joint health, menopausal symptoms, and the specific motivational barriers women report - may deliver outsized cognitive returns.

The Window That Matters Most: Midlife

The research increasingly points to midlife - roughly the 40s and 50s - as the window during which the risk factors identified in this study do their most consequential damage. This is when the menopausal transition is occurring, when brain metabolism is shifting, when blood pressure and blood sugar levels are beginning to drift upward, and when depression and sleep disruption are at their peak prevalence in women.

Earlier menopause has been independently linked to elevated Alzheimer's risk, and the interaction between early estrogen depletion and reduced synaptic integrity accelerates cognitive decline and elevates tau pathology in ways that are attenuated by menopausal hormone therapy in some populations. This makes midlife not just a convenient intervention window but a biologically critical one - a period when the trajectory of the aging female brain is being actively shaped by the risk factors now identified by this study.

What Women Can Do: An Evidence-Based Action Framework

Cardiovascular and Metabolic Health: The Highest-Priority Intervention

Given this study's finding that hypertension and elevated BMI have stronger negative associations with women's cognition, managing cardiovascular and metabolic health in midlife becomes a dual-purpose priority - protecting the heart and protecting the brain simultaneously.

Specific evidence-based actions:

• Monitor blood pressure regularly and treat hypertension aggressively if it develops - particularly after age 65 when it becomes more prevalent in women than men
• Prioritize aerobic exercise, which independently reduces both blood pressure and insulin resistance while directly stimulating neurogenesis
• Follow a Mediterranean-style dietary pattern, which has been shown to reduce cardiovascular risk markers and is independently associated with slower cognitive aging in multiple prospective studies
• Maintain healthy body weight through midlife, as elevated BMI was specifically linked to poorer cognition in women aged 50 to 60 in this study

Depression: Treat It as a Cognitive Emergency in Midlife Women

For women, the study's finding on depression should reframe how depression is approached in midlife. Symptoms of depression that overlap with menopause - sleep disruption, fatigue, low motivation, reduced social engagement - may be normalized or undertreated precisely when they are exerting maximal cognitive damage. Seeking evaluation and effective treatment for depression in midlife is not merely a quality-of-life issue. It is brain protection.

Sleep: Protect Glymphatic Clearance During the Menopause Window

The overlap between menopausal sleep disruption and the cognitive consequences of poor sleep identified in this study creates a specific clinical target. Women navigating hot flashes, night sweats, and hormonal sleep disruption should be explicitly counseled that improving sleep quality is a dementia prevention strategy - not just a wellness goal. Approaches include sleep hygiene optimization, CBT-I (cognitive behavioral therapy for insomnia), and discussion with a physician about hormonal and non-hormonal options for managing vasomotor symptoms that disrupt sleep.

Hearing Loss: Test Early, Treat Promptly

The finding that hearing loss is associated with worse cognitive outcomes in women - even though it is less common in women than men - suggests that women with hearing loss deserve particularly prompt evaluation and hearing aid provision. Hearing aid use has been shown in randomized trials to reduce the rate of cognitive decline in high-risk individuals. The ACHIEVE trial demonstrated a 48% reduction in cognitive decline over three years in high-risk older adults who received hearing intervention.

Physical Activity: Make It Non-Negotiable

Forty-eight percent of women in this nationally representative cohort were physically inactive. That figure represents a dementia prevention crisis hiding in plain sight. Weight-bearing exercise, aerobic activity, and resistance training all independently reduce multiple risk factors identified in this study - blood pressure, blood sugar, BMI, sleep quality, and depression - while directly stimulating hippocampal neurogenesis and preserving white matter integrity.

Natural Support for Cognitive Health: What the Evidence Supports

Hydroxytyrosol: The Neuroprotective Polyphenol That Reaches the Brain Directly

Among natural compounds studied for cognitive protection, hydroxytyrosol stands out for a rare characteristic: it crosses the blood-brain barrier, delivering antioxidant and anti-inflammatory action directly to brain tissue. Unlike most dietary antioxidants, which work systemically, hydroxytyrosol acts locally in the brain - protecting neurons from oxidative damage and neuroinflammation, two mechanisms that are central to Alzheimer's pathology and that appear to operate more aggressively in the postmenopausal brain.

Research shows that hydroxytyrosol stimulates Brain-Derived Neurotrophic Factor (BDNF) - the key growth protein that supports neuronal survival, plasticity, and new synapse formation. In populations following a Mediterranean diet, higher olive polyphenol intake is consistently correlated with better cognitive function, slower brain aging, and reduced neurodegenerative disease risk. Recent research also shows that hydroxytyrosol influences microRNAs involved in brain function, suggesting it may support neural communication at a molecular level.

Naturem™ Memory+ combines hydroxytyrosol as its core ingredient alongside Lion's Mane mushroom (which stimulates Nerve Growth Factor for neuronal regeneration), Ginkgo biloba (which improves cerebral circulation and recall), Fo-ti and Polygala tenuifolia (which support neuronal protection and memory consolidation). This multi-pathway formula addresses brain health through oxidative protection, neuroinflammation reduction, cerebral circulation support, and neurotrophic activity - mechanisms directly relevant to the biological vulnerabilities identified in this study.

DHA Omega-3: Essential Structural Support for the Aging Female Brain

The brain's primary structural omega-3 fatty acid - docosahexaenoic acid (DHA) - constitutes approximately 15 to 20% of brain fatty acid content and is essential for neuronal membrane stability, synaptic plasticity, and hippocampal function. A meta-analysis of 48 longitudinal studies involving 103,651 participants published in the American Journal of Clinical Nutrition found that dietary intake of omega-3 fatty acids reduces the risk of all-cause dementia or cognitive decline by approximately 20%, with the strongest effects for DHA specifically. Long-term omega-3 supplement users in the ADNI cohort showed a 64% reduced risk of Alzheimer's disease.

DHA supports multiple neuroprotective mechanisms simultaneously - it reduces neuroinflammation, maintains synaptic membrane integrity, supports hippocampal neurogenesis, and modulates neurotransmitter pathways. For women in midlife, when the brain's estrogen-mediated metabolic protection is declining, ensuring adequate DHA intake from either fatty fish or a clean algae-derived omega-3 supplement addresses a foundational nutritional need.

For a full overview of the evidence base connecting omega-3 DHA to cognitive health, explore Naturem™'s guide to algal omega-3 and its neuroprotective mechanisms.

Conclusion: The Science Has Named the Factors - Now Comes the Action

The UC San Diego study published in May 2026 does not identify new risk factors for dementia. What it does - for the first time with a nationally representative sample of over 17,000 adults - is demonstrate quantitatively that the same risk factors carry greater cognitive costs in women. Hypertension, elevated BMI, diabetes, hearing loss, depression, physical inactivity, and poor sleep do not just affect women's brains - they affect them more.

"These differences highlight the importance of considering sex as a key variable in dementia research," said senior author Judy Pa. The path forward she and her colleagues have outlined is one of personalized, sex-informed prevention: interventions calibrated not just by which risk factors a person has, but by how strongly those factors are likely to affect their cognitive trajectory based on their biology.

For the approximately 64 million women in the United States who are in their 40s, 50s, and 60s - navigating the menopausal transition during the very window this research identifies as most critical - the message is both sobering and empowering. The risk factors are modifiable. The window for meaningful intervention is open. The cognitive protection available through blood pressure management, depression treatment, physical activity, hearing care, sleep optimization, and targeted nutritional support including hydroxytyrosol and DHA omega-3 is real, evidence-backed, and available now.

The science has named the factors. The next step is action.

This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before beginning any new supplement regimen or making changes to your medical treatment plan.